Chronic Pain Treatment: A Complete Guide to Evidence-Based Options

Why Chronic Pain Is Different From Acute Pain

When you sprain an ankle, the pain is a useful signal. It tells you something is damaged and pushes you to protect the area while it heals. That’s acute pain working exactly as intended. Chronic pain is a different animal entirely.

After pain persists for three months or more, the nervous system can undergo changes that make the pain self-sustaining, even after the original injury has healed. The brain becomes more sensitive to pain signals, a phenomenon researchers call central sensitization [1]. At the same time, the brain’s own pain-suppressing systems often become less effective. What started as a signal becomes a condition in its own right.

This distinction matters enormously for treatment. Approaches that work for acute pain, like rest and over-the-counter anti-inflammatories, frequently fail for chronic pain because they don’t address what’s actually driving the suffering. Effective chronic pain treatment requires understanding what type of pain is present, what’s sustaining it, and which mechanisms each therapy actually targets.

Types of Chronic Pain and What Drives Them

Chronic pain isn’t one thing. The major categories respond to different treatments, so getting the type right is the first step.

Nociceptive Pain

This is pain from actual or threatened tissue damage, the kind associated with arthritis, injuries, or mechanical back pain. Joints that have lost cartilage, tendons that have degenerated, and discs that have bulged are all ongoing sources of nociceptive pain signals. Regenerative therapies, which aim to repair the underlying tissue, have a strong rationale here.

Neuropathic Pain

Neuropathic pain arises from damage or dysfunction in the nervous system itself. Diabetic peripheral neuropathy, post-herpetic neuralgia, and nerve injury pain fall into this category. It often presents as burning, shooting, or electric-shock sensations. The treatment toolkit here overlaps only partially with nociceptive pain, and medications like gabapentinoids and certain antidepressants play a larger role.

Nociplastic Pain

The newest recognized category, nociplastic pain is pain arising from altered nociception despite no clear evidence of actual or threatened tissue damage. Fibromyalgia is the most well-known example. Central sensitization, altered descending pain modulation, and changes in brain processing are the key drivers. Mind-body approaches, certain medications, and neuromodulation therapies tend to be most effective here [2].

Conventional Treatments: What the Evidence Shows

NSAIDs and Acetaminophen

Nonsteroidal anti-inflammatory drugs (NSAIDs) and acetaminophen are the most commonly used first-line treatments. For mild-to-moderate musculoskeletal pain, they provide meaningful relief. However, long-term use of NSAIDs carries real risks: gastrointestinal bleeding, cardiovascular events, and kidney damage accumulate with years of regular use [3]. They also don’t address the underlying tissue pathology driving pain in many cases.

Anticonvulsants and Antidepressants

Gabapentin, pregabalin, duloxetine, and certain tricyclic antidepressants have solid evidence for neuropathic pain and fibromyalgia. Duloxetine, a serotonin-norepinephrine reuptake inhibitor, is FDA-approved for both diabetic peripheral neuropathy and fibromyalgia, with number-needed-to-treat values around 5 to 6 [4]. These medications work on central pain processing rather than peripheral tissue, which is why they’re effective for conditions where the nervous system itself has changed.

Topical Treatments

Lidocaine patches, diclofenac gel, and capsaicin cream are often underused. They deliver active medication directly to the site of pain with much lower systemic absorption, which means fewer side effects. For localized pain conditions, topicals should often be tried before systemic medications.

Physical Therapy and Exercise

Exercise is one of the few interventions with consistent evidence across nearly all chronic pain conditions. It reduces central sensitization, improves descending pain inhibition, and builds resilience in supporting musculature [5]. The challenge is that people in pain often have difficulty exercising, and generic advice to “exercise more” without specific guidance is rarely helpful. A skilled physical therapist who understands pain neuroscience can make a significant difference in what someone is actually able to do.

Regenerative Medicine Approaches

Regenerative medicine represents a genuine shift in how chronic pain is approached. Rather than managing symptoms indefinitely, these therapies aim to repair the damaged tissue or disrupted biology that generates pain signals in the first place.

Platelet-Rich Plasma (PRP)

PRP is derived from the patient’s own blood. A sample is drawn, spun in a centrifuge to concentrate the platelets, and then injected into the site of pathology. Platelets are rich in growth factors that stimulate tissue repair: platelet-derived growth factor, transforming growth factor-beta, and vascular endothelial growth factor, among others.

For knee osteoarthritis, multiple randomized controlled trials have found PRP to be superior to hyaluronic acid injections and equal to or better than corticosteroids for medium-term pain relief, with less cartilage degradation over time [6]. PRP has also shown benefit for chronic tendinopathies, where the tendon tissue has degenerated rather than acutely torn. The evidence for lateral epicondylitis (tennis elbow), patellar tendinopathy, and plantar fasciitis is reasonably strong.

Prolotherapy

Prolotherapy involves injecting a mildly irritating solution, typically dextrose, into damaged ligaments, tendons, or joints. The controlled irritation triggers a local inflammatory cascade that recruits healing cells and promotes collagen synthesis. Unlike corticosteroids, which suppress inflammation and can weaken tissue with repeated use, prolotherapy works by stimulating the body’s own repair process.

Evidence for prolotherapy has strengthened considerably over the past decade. A systematic review found significant improvements in pain and function for chronic low back pain, with effects persisting at one-year follow-up [7]. For hypermobile joints and chronic ligament laxity, prolotherapy may address a structural problem that other treatments cannot.

Stem Cell Therapy

Mesenchymal stem cells (MSCs), typically derived from bone marrow or adipose tissue, have demonstrated the ability to reduce inflammation, modulate immune responses, and support tissue regeneration. In joints with significant osteoarthritis, stem cell injections have shown improvements in pain and function in early trials, though larger randomized controlled trials are still needed to firmly establish efficacy [8].

The proposed mechanisms go beyond simple tissue replacement. MSCs appear to exert much of their effect through paracrine signaling, secreting growth factors and immunomodulatory molecules that change the local environment in the joint or tissue.

Shockwave Therapy

Extracorporeal shockwave therapy (ESWT) delivers acoustic pulses to tissue, stimulating healing in chronic tendinopathies and calcific deposits. For conditions like calcific shoulder tendinitis, plantar fasciitis, and chronic Achilles tendinopathy, ESWT has demonstrated clinically significant improvements in multiple trials [9]. It’s non-invasive and typically requires only a short series of treatments.

Interventional and Neuromodulation Therapies

Ketamine Infusions

Ketamine, an NMDA receptor antagonist, is one of the most interesting tools in pain medicine for people who haven’t responded to conventional treatments. At sub-anesthetic doses, ketamine can interrupt central sensitization and provide pain relief that outlasts the infusion itself, sometimes by weeks or months [10]. It’s particularly relevant for complex regional pain syndrome (CRPS), fibromyalgia, and chronic pain with a central sensitization component. The evidence base is growing, and it’s increasingly being offered at specialized pain clinics.

Transcranial Magnetic Stimulation (TMS)

Repetitive TMS (rTMS) uses magnetic pulses to modulate neural activity in specific brain regions. For chronic pain, targeting the motor cortex or dorsolateral prefrontal cortex can reduce pain intensity through effects on descending pain modulation and pain perception networks. A meta-analysis of rTMS for chronic pain found significant reductions in pain scores compared to sham stimulation, with effects on neuropathic pain being among the most consistent [11].

Spinal Cord Stimulation

For severe, refractory chronic pain, spinal cord stimulation (SCS) involves implanting electrodes near the spinal cord that deliver electrical impulses to modify pain signals before they reach the brain. Modern high-frequency and burst SCS protocols have improved outcomes over older approaches. SCS is typically considered after other treatments have failed, and appropriate patient selection is critical to success.

Peptide Therapies

BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protein found in gastric juice. In preclinical research, it has shown remarkable tissue-healing properties: accelerating healing of tendons, ligaments, muscle, and even gut tissue, in part through upregulation of growth hormone receptors and promotion of angiogenesis [12]. While human clinical trials are still limited, many practitioners are using BPC-157 for chronic musculoskeletal conditions, particularly where tendon or ligament pathology is central to the pain.

TB-500, a synthetic version of Thymosin Beta-4, similarly promotes tissue repair and has shown anti-inflammatory effects in preclinical models. Like BPC-157, its use in clinical practice currently outpaces the formal clinical trial evidence, but the mechanistic rationale is strong and anecdotal reports are compelling.

Psychological and Mind-Body Approaches

Given that chronic pain involves changes in the brain and nervous system, psychological approaches are not an alternative to “real” treatment. They are part of the biological treatment of a biological condition. Cognitive-behavioral therapy (CBT) for chronic pain has among the best evidence of any pain intervention, with durable reductions in pain intensity, disability, and psychological distress [13]. Pain neuroscience education, which teaches patients about central sensitization and the biology of pain, reduces pain catastrophizing and improves function.

Neurofeedback, which trains patients to alter their own brainwave patterns using real-time EEG feedback, has shown promise for chronic pain conditions including fibromyalgia and CRPS, with some evidence for changes in pain-related brain activity. Mindfulness-based stress reduction (MBSR) also has a solid evidence base for reducing pain interference with daily life, even when it doesn’t dramatically reduce pain intensity scores.

Building a Treatment Plan That Works

The key insight from pain research over the past two decades is that chronic pain requires a multimodal approach. A single treatment, no matter how effective in trials, rarely provides complete relief for most people with established chronic pain. Combining therapies that work on different mechanisms, tissue repair plus central sensitization plus psychological factors, consistently outperforms any single-modality approach.

What this looks like in practice: a person with chronic low back pain from degenerative disc disease might benefit from a combination of prolotherapy or PRP injections targeting the structural pathology, physical therapy to build supporting musculature, and pain neuroscience education to address the central sensitization that has developed over years of pain. Adding a short course of duloxetine or a series of ketamine infusions might further reduce the central sensitization component.

Getting there requires working with clinicians who understand the full range of options and aren’t locked into a single treatment philosophy. The best outcomes in chronic pain come from individualized, mechanism-based treatment plans, not protocols applied uniformly.

Related Reading

• Chronic Pain Syndrome: When Pain Becomes a Disease
• Neuropathic Pain Treatment: From Medications to Regenerative Approaches
• Pain Management Without Opioids: Safer Alternatives That Work
• Prolotherapy Injections: How They Work and What to Expect
• PRP Therapy: What the Research Actually Shows
• Ketamine Infusion Therapy for Pain and Depression
• Fibromyalgia Treatment: Evidence-Based Options

References

1. Woolf CJ. “Central sensitization: Implications for the diagnosis and treatment of pain.” Pain. 2011;152(3 Suppl):S2-15. doi:10.1016/j.pain.2010.09.030
2. Kosek E, Cohen M, Baron R, et al. “Do we need a third mechanistic descriptor for chronic pain states?” Pain. 2016;157(7):1382-1386. doi:10.1097/j.pain.0000000000000507
3. Bhala N, Emberson J, Merhi A, et al. “Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.” Lancet. 2013;382(9894):769-779. doi:10.1016/S0140-6736(13)60900-9
4. Lunn MP, Hughes RA, Wiffen PJ. “Duloxetine for treating painful neuropathy, chronic pain or fibromyalgia.” Cochrane Database Syst Rev. 2014;(1):CD007115. doi:10.1002/14651858.CD007115.pub3
5. Geneen LJ, Moore RA, Clarke C, Martin D, Colvin LA, Smith BH. “Physical activity and exercise for chronic pain in adults: an overview of Cochrane Reviews.” Cochrane Database Syst Rev. 2017;4(4):CD011279. doi:10.1002/14651858.CD011279.pub3
6. Dai WL, Zhou AG, Zhang H, Zhang J. “Efficacy of Platelet-Rich Plasma in the Treatment of Knee Osteoarthritis: A Meta-analysis of Randomized Controlled Trials.” Arthroscopy. 2017;33(3):659-670. doi:10.1016/j.arthro.2016.09.024
7. Hauser RA, Lackner JB, Steilen-Matias D, Harris DK. “A Systematic Review of Dextrose Prolotherapy for Chronic Musculoskeletal Pain.” Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:139-159. doi:10.4137/CMAMD.S39160
8. Centeno C, Sheinkop M, Dodson E, et al. “A specific protocol of autologous bone marrow concentrate and platelet products versus exercise therapy for symptomatic knee osteoarthritis: a randomized controlled trial with 2 year follow-up.” J Transl Med. 2018;16(1):355. doi:10.1186/s12967-018-1736-8
9. Leal C, Ramon S, Furia J, et al. “Current concepts of shockwave therapy in chronic calcific tendinitis of the shoulder.” Int J Surg. 2015;24(Pt B):188-193. doi:10.1016/j.ijsu.2015.07.715
10. Orhurhu V, Orhurhu MS, Bhatia A, Cohen SP. “Ketamine Infusions for Chronic Pain: A Systematic Review and Meta-analysis of Randomized Controlled Trials.” Anesth Analg. 2019;129(1):241-254. doi:10.1213/ANE.0000000000004185
11. Lefaucheur JP, Aleman A, Baeken C, et al. “Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS): An update (2014-2018).” Clin Neurophysiol. 2020;131(2):474-528. doi:10.1016/j.clinph.2019.11.002
12. Sikiric P, Seiwerth S, Rucman R, et al. “Stable gastric pentadecapeptide BPC 157: novel therapy in gastrointestinal tract.” Curr Pharm Des. 2011;17(16):1612-1632. doi:10.2174/138161211796196954
13. Williams AC, Fisher E, Hearn L, Eccleston C. “Psychological therapies for the management of chronic pain (excluding headache) in adults.” Cochrane Database Syst Rev. 2020;8(8):CD007407. doi:10.1002/14651858.CD007407.pub4